Vivos Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Vivos Therapeutics has a total shareholder equity of $7.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $15.3M and $7.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$6.31m |
Equity | US$7.67m |
Total liabilities | US$7.68m |
Total assets | US$15.35m |
Recent financial health updates
Recent updates
Even With A 27% Surge, Cautious Investors Are Not Rewarding Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Performance Completely
Nov 12Vivos Therapeutics, Inc.'s (NASDAQ:VVOS) Shares Leap 41% Yet They're Still Not Telling The Full Story
Sep 10It's Down 44% But Vivos Therapeutics, Inc. (NASDAQ:VVOS) Could Be Riskier Than It Looks
Apr 25It's Down 48% But Vivos Therapeutics, Inc. (NASDAQ:VVOS) Could Be Riskier Than It Looks
Feb 02Fewer Investors Than Expected Jumping On Vivos Therapeutics, Inc. (NASDAQ:VVOS)
Apr 18Vivos Therapeutics again delays Q2 2022 results
Aug 23Vivos Therapeutics signs exclusive distribution agreement with GM Instruments for US and Canada
Jun 29Vivos Therapeutics, Inc. (NASDAQ:VVOS) Analysts Are More Bearish Than They Used To Be
May 21Vivos Therapeutics: First Take After The Broad Market Sell-Off
Mar 06Financial Position Analysis
Short Term Liabilities: VVOS's short term assets ($7.4M) exceed its short term liabilities ($5.1M).
Long Term Liabilities: VVOS's short term assets ($7.4M) exceed its long term liabilities ($2.6M).
Debt to Equity History and Analysis
Debt Level: VVOS is debt free.
Reducing Debt: VVOS has no debt compared to 5 years ago when its debt to equity ratio was 1752.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VVOS has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: VVOS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 16.2% each year